Nasdaq: KYTX
Kyverna Therapeutics insiders
The officers, directors and 10% owners of Kyverna Therapeutics, Inc. who hold the most stock, valued at the live KYTX price.
$4.37
KYTX today −$110K (−2.46%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their KYTX stock
- $20.0M
- Market value
- $276M
- Held by ranked insiders
- 7.24%
Insiders by value of KYTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 10% owner | 4,126,119 | $18.0M | 6.53% | Corporate |
| 2 | Peter Maag | Chief Executive Officer | 407,541 | $1.8M | 0.64% | 4518th |
| 3 | Beth C. Seidenberg | Director | 21,727 | $95K | <0.1% | 6363rd |
| 4 | Fred E. Cohen | Director | 21,727 | $95K | <0.1% | 6366th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kyverna Therapeutics; see each profile for the filing.